Alabama
Anniston; Pinnacle Research Group
Parkinson's Disease - Onset of Motor Complications.
Birmingham; University of Alabama at Birmingham
Parkinson's Disease - Onset of Motor Complications.
Birmingham; UCB Clinical Trial Call Center
Trial to Assess PD Symptom Control to Four Doses of Rotigotine in a Transdermal Patch
Hoover; Clinical Research Consultants, Inc.
Parkinson's Disease - Onset of Motor Complications.
Huntsville; UCB Clinical Trial Call Center
Trial to Assess PD Symptom Control to Four Doses of Rotigotine in a Transdermal Patch
Tuscaloosa; UCB Clinical Trial Call Center
Trial to Assess PD Symptom Control to Four Doses of Rotigotine in a Transdermal Patch
Arizona
Gilbert; UCB Clinical Trial Call Center
Trial to Assess PD Symptom Control to Four Doses of Rotigotine in a Transdermal Patch
Peoria; Pivotal Research Centers, LLC
Parkinson's Disease...Does your medicine stop working before your next dose is due?
Peoria; UCB Clinical Trial Call Center
Trial to Assess PD Symptom Control to Four Doses of Rotigotine in a Transdermal Patch
Phoenix; Phoenix Neurological Associates, LTD.
Parkinson's Disease - Onset of Motor Complications.
Phoenix; UCB Clinical Trial Call Center
Trial to Assess PD Symptom Control to Four Doses of Rotigotine in a Transdermal Patch
Scottsdale; UCB Clinical Trial Call Center
Trial to Assess PD Symptom Control to Four Doses of Rotigotine in a Transdermal Patch
Sun City; Sun Health Research Institute
Phase II - Assessing the efficacy and safety of a new investigational drug when used together with a stable dose of L-dopa in the treatment of Parkinson's Disease
Sun City; Sun Health Research Institute
Phase II - Determining Mirapex ER efficacy, safety and tolerability in the treatment Parkinson's Disease
Tucson; Advanced Clinical Therapeutics, LLC
Parkinson's Disease - Onset of Motor Complications.
Various Cities; Research Center
Parkinson's Disease Study CELC200AUS14
Various Cities; Research Center
Parkinson's Disease Dementia Study CENA713B2315
Arkansas
Little Rock; UCB Clinical Trial Call Center
Trial to Assess PD Symptom Control to Four Doses of Rotigotine in a Transdermal Patch
California
Fountain valley; The Parkinson's and Movement Disorder Institute
A clinical study designed to help reduce uncontrolled movements and rigidity caused by levodopa in people with Parkinson’s disease.
Fountain Valley; UCB Clinical Trial Call Center
Trial to Assess PD Symptom Control to Four Doses of Rotigotine in a Transdermal Patch
Fresno; UCB Clinical Trial Call Center
Trial to Assess PD Symptom Control to Four Doses of Rotigotine in a Transdermal Patch
Fresno; The Margolin Brain Institute
Parkinson’s Patients
La Jolla; Coastal Neurological Medical Group
A clinical study designed to help reduce uncontrolled movements and rigidity caused by levodopa in people with Parkinson’s disease.
La Jolla; Coastal Neurological Medical Group
A clinical study designed to help reduce uncontrolled movements and rigidity caused by levodopa in people with Parkinson’s disease.
La Jolla; UCB Clinical Trial Call Center
Trial to Assess PD Symptom Control to Four Doses of Rotigotine in a Transdermal Patch
La Jolla; Coastal Neurological Medical Group, Inc.
A Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of Trimethobenzamide (Tigan®) in the Control of Nausea and Vomiting During Initiation and Continued Treatment With Subcutaneous Apomorphine (Apokyn®) in Apomorphine-naïve Patients With Parkinson's Disease Suffering From Acute Intermittent "Off" Episodes, With Phased Withdrawal of Patients From Tigan® to Placebo
Loma Linda; UCB Clinical Trial Call Center
Trial to Assess PD Symptom Control to Four Doses of Rotigotine in a Transdermal Patch
Los Angeles; Keck/USC School of Medicine, Ctr. For Movement Disorders, Dept. of Neurology
Parkinson's Disease - Onset of Motor Complications.
Newport Beach; Clinical Neurology and Electromyography
Parkinson's Disease - Onset of Motor Complications.
Oxnard; Research Site
Parkinson's Disease - Onset of Motor Complications.
Reseda; UCB Clinical Trial Call Center
Randomized Evaluation of the 24-Hour Coverage: Efficacy of Rotigotine
San Jose; San Jose Medical Group
Parkinson's Disease - Onset of Motor Complications.
Various Cities; Research Center
Parkinson's Disease Study CELC200AUS14
Ventura; UCB Clinical Trial Call Center
Randomized Evaluation of the 24-Hour Coverage: Efficacy of Rotigotine
Walnut Creek; Dr. Michael Stein Neurology-Electroencephalography
Parkinson's Disease - Onset of Motor Complications.
Colorado
Boulder; Alpine Clinical Research
Parkinson's Disease - Onset of Motor Complications.
Englewood; UCB Clinical Trial Call Center
Randomized Evaluation of the 24-Hour Coverage: Efficacy of Rotigotine
Fort Collins; Neurology Associates of Northern Colorado
A clinical study designed to help reduce uncontrolled movements and rigidity caused by levodopa in people with Parkinson’s disease.
Fort Collins; Neurology Associates of Northern Colorado
A clinical study designed to help reduce uncontrolled movements and rigidity caused by levodopa in people with Parkinson’s disease.
Connecticut
Danbury; Biomedical Research Alliance of New York
A clinical study to test the safety, efficacy, and tolerability of an experimental drug in Parkinson’s Disease Patients with Motor Fluctuations.
New Haven; Molecular Neuroimaging, LLC
A clinical study designed to help reduce uncontrolled movements and rigidity caused by levodopa in people with Parkinson’s disease.
New Haven; Molecular Neuroimaging, LLC
A clinical study designed to help reduce uncontrolled movements and rigidity caused by levodopa in people with Parkinson’s disease.
New Haven; UCB Clinical Trial Call Center
Trial to Assess PD Symptom Control to Four Doses of Rotigotine in a Transdermal Patch
Florida
Boca Raton; Parkinson's Disease and Movement Disorder Center of Boca Raton
A clinical study designed to help reduce uncontrolled movements and rigidity caused by levodopa in people with Parkinson’s disease.
Boca Raton; Parkinson's Disease and Movement Disorder Center of Boca Raton
A clinical study designed to help reduce uncontrolled movements and rigidity caused by levodopa in people with Parkinson’s disease.
Boca Raton; UCB Clinical Trial Call Center
Trial to Assess PD Symptom Control to Four Doses of Rotigotine in a Transdermal Patch
Boca Raton; Parkinson's Disease and Movement Disorder Center
Parkinson's Disease - Onset of Motor Complications.
Bradenton; UCB Clinical Trial Call Center
Trial to Assess PD Symptom Control to Four Doses of Rotigotine in a Transdermal Patch
Bradenton; Bradenton Research
Have you been recently diagnosed with Parkinson's Disease?
Clearwater; Morton Plant Mease Research
A clinical study designed to help reduce uncontrolled movements and rigidity caused by levodopa in people with Parkinson’s disease.
Delray Beach; Brain Matters Research
A clinical study designed to help reduce uncontrolled movements and rigidity caused by levodopa in people with Parkinson’s disease.
Hollywood; Sunrise Clinical Research, Inc.
Parkinson's Disease - Onset of Motor Complications.
Jacksonville; UCB Clinical Trial Call Center
Trial to Assess PD Symptom Control to Four Doses of Rotigotine in a Transdermal Patch
Miami; UCB Clinical Trial Call Center
Trial to Assess PD Symptom Control to Four Doses of Rotigotine in a Transdermal Patch
Miami; Miami Research Associates
Parkinson's Disease - Onset of Motor Complications.
Naples; UCB Clinical Trial Call Center
Trial to Assess PD Symptom Control to Four Doses of Rotigotine in a Transdermal Patch
Pembroke Pines; Broward Research Group
Parkinson's Disease - Onset of Motor Complications.
Plantation; Neurology Clinical Research Inc.
Parkinson's Disease - Onset of Motor Complications.
Pompano Beach; UCB Clinical Trial Call Center
Trial to Assess PD Symptom Control to Four Doses of Rotigotine in a Transdermal Patch
Port Charlotte; Charlotte Neurological Services
Parkinson's Disease - Onset of Motor Complications.
Port Charlotte; Charlotte Neurological Services
A Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of Trimethobenzamide (Tigan®) in the Control of Nausea and Vomiting During Initiation and Continued Treatment With Subcutaneous Apomorphine (Apokyn®) in Apomorphine-naïve Patients With Parkinson's Disease Suffering From Acute Intermittent "Off" Episodes, With Phased Withdrawal of Patients From Tigan® to Placebo
St. Petersburg; UCB Clinical Trial Call Center
Randomized Evaluation of the 24-Hour Coverage: Efficacy of Rotigotine
St. Petersburg; UCB Clinical Trial Call Center
Trial to Assess PD Symptom Control to Four Doses of Rotigotine in a Transdermal Patch
Sunrise; UCB Clinical Trial Call Center
Trial to Assess PD Symptom Control to Four Doses of Rotigotine in a Transdermal Patch
Tampa; University of South Florida, Dept. of Neurology
Parkinson's Disease - Onset of Motor Complications.
Tampa; USF: Parkinson's Disease and Movement Disorders Center
A clinical study designed to help reduce uncontrolled movements and rigidity caused by levodopa in people with Parkinson’s disease.
Tampa; USF: Parkinson's Disease and Movement Disorders Center
A clinical study designed to help reduce uncontrolled movements and rigidity caused by levodopa in people with Parkinson’s disease.
Tampa; University of South Florida, Dept. of Neurology
Parkinson's Disease - Onset of Motor Complications.
Various Cities; Research Center
Parkinson's Disease Study CELC200AUS14
Georgia
Atlanta; Emory University School of Medicine Wesley Woods Health Center
A clinical study designed to help reduce uncontrolled movements and rigidity caused by levodopa in people with Parkinson’s disease.
Augusta; Medical College of Georgia
Parkinson's Disease - Onset of Motor Complications.
Decatur; Dekalb Neurology Associates
Parkinson's Disease - Onset of Motor Complications.
Decatur; UCB Clinical Trial Call Center
Trial to Assess PD Symptom Control to Four Doses of Rotigotine in a Transdermal Patch
Macon; UCB Clinical Trial Call Center
Trial to Assess PD Symptom Control to Four Doses of Rotigotine in a Transdermal Patch
Marietta; Radiant Research
Parkinson's Disease - Onset of Motor Complications.
Idaho
Boise; Karin Lindholm, DO
Parkinson's Disease - Onset of Motor Complications.
Illinois
Chicago; UCB Clinical Trial Call Center
Trial to Assess PD Symptom Control to Four Doses of Rotigotine in a Transdermal Patch
Chicago; University of Chicago
Parkinson's Disease - Onset of Motor Complications.
Hoffman Estates; Radiant Research at Alexian Brothers Neurosciences Institute
Parkinson's Disease - Onset of Motor Complications.
Northbrook; Consultants in Neurology
Parkinson's Disease - Onset of Motor Complications.
Indiana
Anderson; UCB Clinical Trial Call Center
Trial to Assess PD Symptom Control to Four Doses of Rotigotine in a Transdermal Patch
Elkhart; UCB Clinical Trial Call Center
Trial to Assess PD Symptom Control to Four Doses of Rotigotine in a Transdermal Patch
Iowa
Des Moines; Iowa Health Physicians, Methodist Plaza Subspecialty
Parkinson's Disease - Onset of Motor Complications.
Des Moines; UCB Clinical Trial Call Center
Trial to Assess PD Symptom Control to Four Doses of Rotigotine in a Transdermal Patch
Kansas
Kansas City; Kansas University Medical Center
Parkinson's Disease - Onset of Motor Complications.
Kansas City; UCB Clinical Trial Call Center
Trial to Assess PD Symptom Control to Four Doses of Rotigotine in a Transdermal Patch
Various Cities; Research Center
Parkinson's Disease Study CELC200AUS14
Kentucky
Lexington; University of Kentucky Chandler Medical Center
Volunteers Needed for Parkinson’s Disease Research Study
Lexington; University of Kentucky Chandler Medical Center
Announcing a Research Study for Patients with Parkinson’s Disease
Lexington; University of Kentucky Chandler Medical Center
Volunteers Needed for Research Study on Parkinson’s Disease
Louisville; UCB Clinical Trial Call Center
Trial to Assess PD Symptom Control to Four Doses of Rotigotine in a Transdermal Patch
Maryland
Elkridge; Parkinson's and Movement Disorders Center of Maryland
A Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of Trimethobenzamide (Tigan®) in the Control of Nausea and Vomiting During Initiation and Continued Treatment With Subcutaneous Apomorphine (Apokyn®) in Apomorphine-naïve Patients With Parkinson's Disease Suffering From Acute Intermittent "Off" Episodes, With Phased Withdrawal of Patients From Tigan® to Placebo
Various Cities; Research Center
Parkinson's Disease Study CELC200AUS14
Massachusetts
Boston; UCB Clinical Trial Call Center
Trial to Assess PD Symptom Control to Four Doses of Rotigotine in a Transdermal Patch
Michigan
Bingham Farms; QUEST Research Institute
Advanced Parkinson's Disease
Grand Rapids; Saint Mary's Health Care - Hauenstein Parkinson's Center
A clinical study designed to help reduce uncontrolled movements and rigidity caused by levodopa in people with Parkinson’s disease.
Southfield; Henry Ford Health System: Franklin Pointe Medical Center
A clinical study designed to help reduce uncontrolled movements and rigidity caused by levodopa in people with Parkinson’s disease.
Southfield; UCB Clinical Trial Call Center
Trial to Assess PD Symptom Control to Four Doses of Rotigotine in a Transdermal Patch
Traverse City; Northern Michigan Neurology (America's Doctors)
Parkinson's Disease - Onset of Motor Complications.
Minnesota
Golden Valley; UCB Clinical Trial Call Center
Trial to Assess PD Symptom Control to Four Doses of Rotigotine in a Transdermal Patch
Missouri
St Louis; UCB Clinical Trial Call Center
Trial to Assess PD Symptom Control to Four Doses of Rotigotine in a Transdermal Patch
St. Louis; Washington University School of Medicine
Parkinson's Disease - Onset of Motor Complications.
Various Cities; Research Center
Parkinson's Disease Study CELC200AUS14
Montana
Missoula; UCB Clinical Trial Call Center
Trial to Assess PD Symptom Control to Four Doses of Rotigotine in a Transdermal Patch
Nebraska
Omaha; UCB Clinical Trial Call Center
Trial to Assess PD Symptom Control to Four Doses of Rotigotine in a Transdermal Patch
Various Cities; Research Center
Parkinson's Disease Study CELC200AUS14
New Hampshire
Lebanon; Ayres and Associates Clinical Trials
Parkinson's Disease - Onset of Motor Complications.
New Jersey
Edison; New Jersey Neuroscience Institute at JFK Medical Ctr.
Parkinson's Disease - Onset of Motor Complications.
New York
Albany; Parkinson's Disease and Movement Disorder Center
Parkinson's Disease - Onset of Motor Complications.
Albany; Upstate Clinical Research
Parkinson's Disease - Onset of Motor Complications.
Brooklyn; UCB Clinical Trial Call Center
Randomized Evaluation of the 24-Hour Coverage: Efficacy of Rotigotine
Commack; UCB Clinical Trial Call Center
Trial to Assess PD Symptom Control to Four Doses of Rotigotine in a Transdermal Patch
Forest Hills; Biomedical Research Alliance of New York
Parkinson’s Disease with Motor Fluctuations - Adults
Forest Hills; Biomedical Research Alliance of New York
A clinical study to test the safety, efficacy, and tolerability of an experimental drug in Parkinson’s Disease Patients with Motor Fluctuations
Manhasset; Biomedical Research Alliance of New York
A clinical study to test the safety, efficacy, and tolerability of an experimental drug in Parkinson’s Disease Patients with Motor Fluctuations
New York; Mount Sinai Medical Center
Parkinson Disease Collaborative Study of Genetic Linkage
New York; UCB Clinical Trial Call Center
Trial to Assess PD Symptom Control to Four Doses of Rotigotine in a Transdermal Patch
New York; Biomedical Research Alliance of New York
Patient Programmer and Recharger system for DBS: Usability study - Adults and Minors
New York; Biomedical Research Alliance of New York
Parkinson’s Disease- Adults
New York; Biomedical Research Alliance of New York
Parkinson's Disease
New York; Biomedical Research Alliance of New York
Tremor Supression
New York; Biomedical Research Alliance of New York
Parkinson's Disease - Deep Brain Stimulation
New York; Biomedical Research Alliance of New York
People with Parkinson’s Disease psychosis are asked to participate in a research study being conducted by Mount Sinai Medical Center.
Rochester; UCB Clinical Trial Call Center
Trial to Assess PD Symptom Control to Four Doses of Rotigotine in a Transdermal Patch
Various Cities; Research Center
Parkinson's Disease Study CELC200AUS14
North Carolina
Asheville; Asheville Neurology Specialists, PA
Parkinson's Disease - Onset of Motor Complications.
Asheville; UCB Clinical Trial Call Center
Trial to Assess PD Symptom Control to Four Doses of Rotigotine in a Transdermal Patch
Chapel Hill; UNC Chapel Hill, Dept. of Neurology
Parkinson's Disease - Onset of Motor Complications.
Durham; Duke University Medical Center
A clinical study designed to help reduce uncontrolled movements and rigidity caused by levodopa in people with Parkinson’s disease.
Raleigh; Raleigh Neurology Associates
Parkinson's Disease - Onset of Motor Complications.
Raleigh; UCB Clinical Trial Call Center
Trial to Assess PD Symptom Control to Four Doses of Rotigotine in a Transdermal Patch
Raleigh; Raleigh Neurology Associates
A Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of Trimethobenzamide (Tigan®) in the Control of Nausea and Vomiting During Initiation and Continued Treatment With Subcutaneous Apomorphine (Apokyn®) in Apomorphine-naïve Patients With Parkinson's Disease Suffering From Acute Intermittent "Off" Episodes, With Phased Withdrawal of Patients From Tigan® to Placebo
Salisbury; UCB Clinical Trial Call Center
Randomized Evaluation of the 24-Hour Coverage: Efficacy of Rotigotine
Salisbury; UCB Clinical Trial Call Center
Trial to Assess PD Symptom Control to Four Doses of Rotigotine in a Transdermal Patch
Salisbury; Central Carolina Neurology & Sleep, PA
24-Hour Treatment for Parkinson's Patient
Various Cities; Research Center
Parkinson's Disease Study CELC200AUS14
Winston-Salem; The Center for Clinical Research, LLC
Parkinson's Disease - Onset of Motor Complications.
Ohio
Canton; UCB Clinical Trial Call Center
Trial to Assess PD Symptom Control to Four Doses of Rotigotine in a Transdermal Patch
Columbus; UCB Clinical Trial Call Center
Trial to Assess PD Symptom Control to Four Doses of Rotigotine in a Transdermal Patch
Toledo; UCB Clinical Trial Call Center
Trial to Assess PD Symptom Control to Four Doses of Rotigotine in a Transdermal Patch
Toledo; University of Toledo
A clinical study designed to help reduce uncontrolled movements and rigidity caused by levodopa in people with Parkinson’s disease.
Various Cities; Research Center
Parkinson's Disease Dementia Study CENA713B2315
Oregon
Eugene; Oregon Center for Clinical Research
Parkinson's Disease - Onset of Motor Complications.
Medford; Medford Medical Clinic
Parkinson's Disease - Onset of Motor Complications.
Pennsylvania
Greensburg; UCB Clinical Trial Call Center
Trial to Assess PD Symptom Control to Four Doses of Rotigotine in a Transdermal Patch
Philadelphia; University of Pennsylvania, Penn Neurological Institute
Parkinson's Disease - Onset of Motor Complications.
Pittsburgh; UCB Clinical Trial Call Center
Trial to Assess PD Symptom Control to Four Doses of Rotigotine in a Transdermal Patch
Souderton; UCB Clinical Trial Call Center
Trial to Assess PD Symptom Control to Four Doses of Rotigotine in a Transdermal Patch
Upland; UCB Clinical Trial Call Center
Trial to Assess PD Symptom Control to Four Doses of Rotigotine in a Transdermal Patch
Various Cities; Research Center
Parkinson's Disease Dementia Study CENA713B2315
Various Cities; Research Center
Parkinson's Disease Study CELC200AUS14
Rhode Island
Warwick; UCB Clinical Trial Call Center
Randomized Evaluation of the 24-Hour Coverage: Efficacy of Rotigotine
Tennessee
Brentwood; Brentwood Neurology, PC
A clinical study designed to help reduce uncontrolled movements and rigidity caused by levodopa in people with Parkinson’s disease.
Brentwood; Brentwood Neurology, PC
A clinical study designed to help reduce uncontrolled movements and rigidity caused by levodopa in people with Parkinson’s disease.
Memphis; UCB Clinical Trial Call Center
Trial to Assess PD Symptom Control to Four Doses of Rotigotine in a Transdermal Patch
Various Cities; Research Center
Parkinson's Disease Study CELC200AUS14
Texas
Austin; FutureSearch Trials
Parkinson's Disease - Onset of Motor Complications.
Dallas; Neurology Specialist of Dallas PA
Parkinson's Disease - Onset of Motor Complications.
Dallas; Radiant Research - Dallas North
Parkinson’s Research
Houston; Baylor College of Medicine
A Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of Trimethobenzamide (Tigan®) in the Control of Nausea and Vomiting During Initiation and Continued Treatment With Subcutaneous Apomorphine (Apokyn®) in Apomorphine-naïve Patients With Parkinson's Disease Suffering From Acute Intermittent "Off" Episodes, With Phased Withdrawal of Patients From Tigan® to Placebo
Lubbock; Bhupesh Dihenia, MD
Parkinson's Disease - Onset of Motor Complications.
Lubbock; UCB Clinical Trial Call Center
Trial to Assess PD Symptom Control to Four Doses of Rotigotine in a Transdermal Patch
San Antonio; UCB Clinical Trial Call Center
Randomized Evaluation of the 24-Hour Coverage: Efficacy of Rotigotine
San Antonio; UCB Clinical Trial Call Center
Trial to Assess PD Symptom Control to Four Doses of Rotigotine in a Transdermal Patch
Various Cities; Research Center
Parkinson's Disease Dementia Study CENA713B2315
Various Cities; Research Center
Parkinson's Disease Study CELC200AUS14
Utah
Midvale; UCB Clinical Trial Call Center
Trial to Assess PD Symptom Control to Four Doses of Rotigotine in a Transdermal Patch
Midvale; Pivotal Research Centers, LLC
Parkinson's Disease? Does your medicine stop working before your next dose is due?
Virginia
Alexandria; UCB Clinical Trial Call Center
Trial to Assess PD Symptom Control to Four Doses of Rotigotine in a Transdermal Patch
Alexandria; Research Site
Parkinson's Disease - Onset of Motor Complications.
Charlottesville; University of Virginia![[*]](../images/newtiny.gif)
UVa Health System, Department of Neurology, seeks Woman and Men with Parkinson's Disease for research study.
Richmond; UCB Clinical Trial Call Center
Trial to Assess PD Symptom Control to Four Doses of Rotigotine in a Transdermal Patch
Richmond; International Clinical Research Associates
Parkinson’s Psychosis can be almost as frightening for you as it is for them.
Roanoke; Blue Ridge Research Center
Parkinson's Disease - Onset of Motor Complications.
Roanoke; UCB Clinical Trial Call Center
Trial to Assess PD Symptom Control to Four Doses of Rotigotine in a Transdermal Patch
Washington
Kirkland; Booth Gardner Parkinson's Care Center
A clinical study designed to help reduce uncontrolled movements and rigidity caused by levodopa in people with Parkinson’s disease.
Kirkland; UCB Clinical Trial Call Center
Trial to Assess PD Symptom Control to Four Doses of Rotigotine in a Transdermal Patch
Seattle; Virginia Mason Research Ctr.
Parkinson's Disease - Onset of Motor Complications.
Spokane; UCB Clinical Trial Call Center
Trial to Assess PD Symptom Control to Four Doses of Rotigotine in a Transdermal Patch
Tacoma; Neurology and Neurosurgery Associates of Tacoma, Inc.
Parkinson's Disease - Onset of Motor Complications.
Various Cities; Research Center
Parkinson's Disease Dementia Study CENA713B2315
Washington, DC
Various Cities; Research Center
Parkinson's Disease Study CELC200AUS14
Wisconsin
Milwaukee; UCB Clinical Trial Call Center
Trial to Assess PD Symptom Control to Four Doses of Rotigotine in a Transdermal Patch
International
Adelaide, South Australia, Australia; UCB Clinical Trial Call Center
Randomized Evaluation of the 24-Hour Coverage: Efficacy of Rotigotine
Brisbane, Queensland, Australia; UCB Clinical Trial Call Center
Randomized Evaluation of the 24-Hour Coverage: Efficacy of Rotigotine
Concord, New South Wales, Australia; UCB Clinical Trial Call Center
Randomized Evaluation of the 24-Hour Coverage: Efficacy of Rotigotine
Fitzroy, Australia; UCB Clinical Trial Call Center
Randomized Evaluation of the 24-Hour Coverage: Efficacy of Rotigotine
Innsbruck, Austria; UCB Clinical Trial Call Center
Randomized Evaluation of the 24-Hour Coverage: Efficacy of Rotigotine
London, Ontario, Canada; London Health Sciences Center University Campus
A clinical study designed to help reduce uncontrolled movements and rigidity caused by levodopa in people with Parkinson’s disease.
Montreal, Quebec, Canada; Notre Dame
A clinical study designed to help reduce uncontrolled movements and rigidity caused by levodopa in people with Parkinson’s disease.
San Miguel, Santiago, Chile; Complejo Asistencial Barros Luco
A clinical study designed to help reduce uncontrolled movements and rigidity caused by levodopa in people with Parkinson’s disease.
Bogota, Colombia; Asociacion Medica De Los Andes
A clinical study designed to help reduce uncontrolled movements and rigidity caused by levodopa in people with Parkinson’s disease.
Bucaramanga, Colombia; Fundacion Cardiovascular del Oriente Colombiano
A clinical study designed to help reduce uncontrolled movements and rigidity caused by levodopa in people with Parkinson’s disease.
Hyvinkää, Finland; UCB Clinical Trial Call Center
Randomized Evaluation of the 24-Hour Coverage: Efficacy of Rotigotine
Oulu, Finland; UCB Clinical Trial Call Center
Randomized Evaluation of the 24-Hour Coverage: Efficacy of Rotigotine
Lille cedex, France; C.H.R.U de Lille, Hopital R. Salengro Service de Neuroligie A
A clinical study designed to help reduce uncontrolled movements and rigidity caused by levodopa in people with Parkinson’s disease.
Marseille Cedex 05, France; A.P. Marseille, Hopital de la Timone
A clinical study designed to help reduce uncontrolled movements and rigidity caused by levodopa in people with Parkinson’s disease.
Nantes Cedex 1, France; C.H.R.U de nantes Hopital Guillaume et Rene Laenn
A clinical study designed to help reduce uncontrolled movements and rigidity caused by levodopa in people with Parkinson’s disease.
Achim, Germany; UCB Clinical Trial Call Center
Transdermal Rotigotine User Surveillance Study
Annaberg-Buchholz, Germany; UCB Clinical Trial Call Center
Transdermal Rotigotine User Surveillance Study
Augsburg, Germany; UCB Clinical Trial Call Center
A Trial of Neupro® (Rotigotine Transdermal Patch) in Patients With Parkinson's Disease Undergoing Surgery.
Augsburg, Germany; UCB Clinical Trial Call Center
Transdermal Rotigotine User Surveillance Study
Böblingen, Germany; UCB Clinical Trial Call Center
Transdermal Rotigotine User Surveillance Study
Bad Neustadt, Germany; UCB Clinical Trial Call Center
Transdermal Rotigotine User Surveillance Study
Bamberg, Germany; UCB Clinical Trial Call Center
Transdermal Rotigotine User Surveillance Study
Berg, Germany; UCB Clinical Trial Call Center
Transdermal Rotigotine User Surveillance Study
Berlin, Germany; UCB Clinical Trial Call Center
Randomized Evaluation of the 24-Hour Coverage: Efficacy of Rotigotine
Berlin, Germany; UCB Clinical Trial Call Center
Randomized Evaluation of the 24-Hour Coverage: Efficacy of Rotigotine
Berlin, Germany; UCB Clinical Trial Call Center
Transdermal Rotigotine User Surveillance Study
Berlin, Germany; UCB Clinical Trial Call Center
Randomized Evaluation of the 24-Hour Coverage: Efficacy of Rotigotine
Bielefeld, Germany; UCB Clinical Trial Call Center
Transdermal Rotigotine User Surveillance Study
Blankenberg (Harz), Germany; UCB Clinical Trial Call Center
Transdermal Rotigotine User Surveillance Study
Bochum, Germany; UCB Clinical Trial Call Center
Transdermal Rotigotine User Surveillance Study
Bochum, Germany; UCB Clinical Trial Call Center
A Trial of Neupro® (Rotigotine Transdermal Patch) in Patients With Parkinson's Disease Undergoing Surgery.
Bonn, Germany; UCB Clinical Trial Call Center
A Trial of Neupro® (Rotigotine Transdermal Patch) in Patients With Parkinson's Disease Undergoing Surgery.
Bonn, Germany; UCB Clinical Trial Call Center
Transdermal Rotigotine User Surveillance Study
Bremerhaven, Germany; UCB Clinical Trial Call Center
A Trial of Neupro® (Rotigotine Transdermal Patch) in Patients With Parkinson's Disease Undergoing Surgery.
Butzbach, Germany; UCB Clinical Trial Call Center
Transdermal Rotigotine User Surveillance Study
Düsseldorf, Germany; UCB Clinical Trial Call Center
Transdermal Rotigotine User Surveillance Study
Dortmund, Germany; UCB Clinical Trial Call Center
A Trial of Neupro® (Rotigotine Transdermal Patch) in Patients With Parkinson's Disease Undergoing Surgery.
Dresden, Germany; UCB Clinical Trial Call Center
Transdermal Rotigotine User Surveillance Study
Dresden, Germany; UCB Clinical Trial Call Center
A Trial of Neupro® (Rotigotine Transdermal Patch) in Patients With Parkinson's Disease Undergoing Surgery.
Dresden, Germany; UCB Clinical Trial Call Center
Randomized Evaluation of the 24-Hour Coverage: Efficacy of Rotigotine
Emmendingen, Germany; UCB Clinical Trial Call Center
Transdermal Rotigotine User Surveillance Study
Erbach, Germany; UCB Clinical Trial Call Center
Transdermal Rotigotine User Surveillance Study
Flensburg, Germany; UCB Clinical Trial Call Center
Transdermal Rotigotine User Surveillance Study
Frankfurt am Main, Germany; UCB Clinical Trial Call Center
Transdermal Rotigotine User Surveillance Study
Friedberg (Hessen), Germany; UCB Clinical Trial Call Center
Transdermal Rotigotine User Surveillance Study
Grevenbroich, Germany; UCB Clinical Trial Call Center
Transdermal Rotigotine User Surveillance Study
Halle (Saale), Germany; UCB Clinical Trial Call Center
Transdermal Rotigotine User Surveillance Study
Hamburg, Germany; UCB Clinical Trial Call Center
Transdermal Rotigotine User Surveillance Study
Hanau, Germany; UCB Clinical Trial Call Center
A Trial of Neupro® (Rotigotine Transdermal Patch) in Patients With Parkinson's Disease Undergoing Surgery.
Hemmoor, Germany; UCB Clinical Trial Call Center
Transdermal Rotigotine User Surveillance Study
Herborn, Germany; UCB Clinical Trial Call Center
Transdermal Rotigotine User Surveillance Study
Hildesheim, Germany; UCB Clinical Trial Call Center
Transdermal Rotigotine User Surveillance Study
Ingolstadt, Germany; UCB Clinical Trial Call Center
A Trial of Neupro® (Rotigotine Transdermal Patch) in Patients With Parkinson's Disease Undergoing Surgery.
Jülich, Germany; UCB Clinical Trial Call Center
Transdermal Rotigotine User Surveillance Study
Köln, Germany; UCB Clinical Trial Call Center
Transdermal Rotigotine User Surveillance Study
Karlstadt, Germany; UCB Clinical Trial Call Center
Transdermal Rotigotine User Surveillance Study
Kassel, Germany; UCB Clinical Trial Call Center
Randomized Evaluation of the 24-Hour Coverage: Efficacy of Rotigotine
Kiel, Germany; UCB Clinical Trial Call Center
A Trial of Neupro® (Rotigotine Transdermal Patch) in Patients With Parkinson's Disease Undergoing Surgery.
Leipzig, Germany; UCB Clinical Trial Call Center
Randomized Evaluation of the 24-Hour Coverage: Efficacy of Rotigotine
Leutkirch im Allgau, Germany; UCB Clinical Trial Call Center
Transdermal Rotigotine User Surveillance Study
Lutherstadt Eisleben, Germany; UCB Clinical Trial Call Center
Transdermal Rotigotine User Surveillance Study
München, Germany; UCB Clinical Trial Call Center
Transdermal Rotigotine User Surveillance Study
Marburg, Germany; UCB Clinical Trial Call Center
Randomized Evaluation of the 24-Hour Coverage: Efficacy of Rotigotine
Munchen, Germany; UCB Clinical Trial Call Center
Randomized Evaluation of the 24-Hour Coverage: Efficacy of Rotigotine
Naumburg, Germany; UCB Clinical Trial Call Center
Randomized Evaluation of the 24-Hour Coverage: Efficacy of Rotigotine
Naumburg (Saale), Germany; UCB Clinical Trial Call Center
Transdermal Rotigotine User Surveillance Study
Neuberg, Germany; UCB Clinical Trial Call Center
Transdermal Rotigotine User Surveillance Study
Oberhausen, Germany; UCB Clinical Trial Call Center
Transdermal Rotigotine User Surveillance Study
Oberursel (Taunus), Germany; UCB Clinical Trial Call Center
Transdermal Rotigotine User Surveillance Study
Oldenburg, Germany; UCB Clinical Trial Call Center
Transdermal Rotigotine User Surveillance Study
Oranienburg, Germany; UCB Clinical Trial Call Center
Transdermal Rotigotine User Surveillance Study
Oranienburg, Germany; UCB Clinical Trial Call Center
Randomized Evaluation of the 24-Hour Coverage: Efficacy of Rotigotine
Osnabrück, Germany; UCB Clinical Trial Call Center
Transdermal Rotigotine User Surveillance Study
Ostfildern, Germany; UCB Clinical Trial Call Center
Transdermal Rotigotine User Surveillance Study
Rheda-Wiedenbrück, Germany; UCB Clinical Trial Call Center
Transdermal Rotigotine User Surveillance Study
Rottenburg am Neckar, Germany; UCB Clinical Trial Call Center
Transdermal Rotigotine User Surveillance Study
Rottweil, Germany; UCB Clinical Trial Call Center
Transdermal Rotigotine User Surveillance Study
Schriesheim, Germany; UCB Clinical Trial Call Center
Transdermal Rotigotine User Surveillance Study
Schwerin, Germany; UCB Clinical Trial Call Center
Transdermal Rotigotine User Surveillance Study
Schwerin, Germany; UCB Clinical Trial Call Center
A Trial of Neupro® (Rotigotine Transdermal Patch) in Patients With Parkinson's Disease Undergoing Surgery.
Singen (Hohentwiel), Germany; UCB Clinical Trial Call Center
Transdermal Rotigotine User Surveillance Study
Starnberg, Germany; UCB Clinical Trial Call Center
Transdermal Rotigotine User Surveillance Study
Stralsund, Germany; UCB Clinical Trial Call Center
A Trial of Neupro® (Rotigotine Transdermal Patch) in Patients With Parkinson's Disease Undergoing Surgery.
Stuttgart, Germany; UCB Clinical Trial Call Center
Transdermal Rotigotine User Surveillance Study
Ulm, Germany; UCB Clinical Trial Call Center
Transdermal Rotigotine User Surveillance Study
Ulm, Germany; UCB Clinical Trial Call Center
A Trial of Neupro® (Rotigotine Transdermal Patch) in Patients With Parkinson's Disease Undergoing Surgery.
Ulm, Germany; UCB Clinical Trial Call Center
Randomized Evaluation of the 24-Hour Coverage: Efficacy of Rotigotine
Unterhaching, Germany; UCB Clinical Trial Call Center
Transdermal Rotigotine User Surveillance Study
Wolfach, Germany; UCB Clinical Trial Call Center
Transdermal Rotigotine User Surveillance Study
Wolfach, Germany; UCB Clinical Trial Call Center
Randomized Evaluation of the 24-Hour Coverage: Efficacy of Rotigotine
Zwickau, Germany; UCB Clinical Trial Call Center
Transdermal Rotigotine User Surveillance Study
Zona 14, Guatemala; Unidad de Diagnostico Cardiologico
A clinical study designed to help reduce uncontrolled movements and rigidity caused by levodopa in people with Parkinson’s disease.
Shatin, New Territories, Hong Kong; U. of Hong Kong, Shatin- Prince of Wales Hospital
A clinical study designed to help reduce uncontrolled movements and rigidity caused by levodopa in people with Parkinson’s disease.
Budapest, Hungary; UCB Clinical Trial Call Center
Randomized Evaluation of the 24-Hour Coverage: Efficacy of Rotigotine
Debrecen, Hungary; UCB Clinical Trial Call Center
Randomized Evaluation of the 24-Hour Coverage: Efficacy of Rotigotine
Debrecen, Hungary; UCB Clinical Trial Call Center
Randomized Evaluation of the 24-Hour Coverage: Efficacy of Rotigotine
Nyiregyhaza, Hungary; UCB Clinical Trial Call Center
Randomized Evaluation of the 24-Hour Coverage: Efficacy of Rotigotine
Pécs, Hungary; UCB Clinical Trial Call Center
Randomized Evaluation of the 24-Hour Coverage: Efficacy of Rotigotine
Zalaegerszeg, Hungary; UCB Clinical Trial Call Center
Randomized Evaluation of the 24-Hour Coverage: Efficacy of Rotigotine
Chieti, Italy; UCB Clinical Trial Call Center
Randomized Evaluation of the 24-Hour Coverage: Efficacy of Rotigotine
Chieti Scalo, Italy; Centro Studi L’invecchiamento Oncology and Neuroscience
A clinical study designed to help reduce uncontrolled movements and rigidity caused by levodopa in people with Parkinson’s disease.
Milano, Italy; UCB Clinical Trial Call Center
Randomized Evaluation of the 24-Hour Coverage: Efficacy of Rotigotine
Milano, Italy; Istituti Clinici di Perfezionamento
A clinical study designed to help reduce uncontrolled movements and rigidity caused by levodopa in people with Parkinson’s disease.
Pavia, Italy; IRCCS Istituto Neurologico “C Mondino
A clinical study designed to help reduce uncontrolled movements and rigidity caused by levodopa in people with Parkinson’s disease.
Pavia, Italy; UCB Clinical Trial Call Center
Randomized Evaluation of the 24-Hour Coverage: Efficacy of Rotigotine
Torino, Italy; UCB Clinical Trial Call Center
Randomized Evaluation of the 24-Hour Coverage: Efficacy of Rotigotine
Christ Church, New Zealand; UCB Clinical Trial Call Center
Randomized Evaluation of the 24-Hour Coverage: Efficacy of Rotigotine
Wellington, New Zealand; UCB Clinical Trial Call Center
Randomized Evaluation of the 24-Hour Coverage: Efficacy of Rotigotine
La Victoria, Lima, Peru; Hospital Nacional Guiillermo Almenarea Irigoyen
A clinical study designed to help reduce uncontrolled movements and rigidity caused by levodopa in people with Parkinson’s disease.
Gdansk, Poland; UCB Clinical Trial Call Center
Randomized Evaluation of the 24-Hour Coverage: Efficacy of Rotigotine
Krakow, Poland; UCB Clinical Trial Call Center
Randomized Evaluation of the 24-Hour Coverage: Efficacy of Rotigotine
Lublin, Poland; UCB Clinical Trial Call Center
Randomized Evaluation of the 24-Hour Coverage: Efficacy of Rotigotine
Olsztyn, Poland; UCB Clinical Trial Call Center
Randomized Evaluation of the 24-Hour Coverage: Efficacy of Rotigotine
Warszawa, Poland; UCB Clinical Trial Call Center
Randomized Evaluation of the 24-Hour Coverage: Efficacy of Rotigotine
Warszawa, Poland; UCB Clinical Trial Call Center
Randomized Evaluation of the 24-Hour Coverage: Efficacy of Rotigotine
Singapore, Singapore; Singapore General Hospital, Department of Neurology
A clinical study designed to help reduce uncontrolled movements and rigidity caused by levodopa in people with Parkinson’s disease.
Singapore, Singapore; National Neuroscience Institute: Dept. of Neurology
A clinical study designed to help reduce uncontrolled movements and rigidity caused by levodopa in people with Parkinson’s disease.
Cape Town, South Africa; UCB Clinical Trial Call Center
Randomized Evaluation of the 24-Hour Coverage: Efficacy of Rotigotine
Capetown, South Africa; UCB Clinical Trial Call Center
Randomized Evaluation of the 24-Hour Coverage: Efficacy of Rotigotine
Johannesburg, South Africa; UCB Clinical Trial Call Center
Randomized Evaluation of the 24-Hour Coverage: Efficacy of Rotigotine
Pretoria, Gauteng, South Africa; willows MR Medical Center
A clinical study designed to help reduce uncontrolled movements and rigidity caused by levodopa in people with Parkinson’s disease.
Pretoria/Gauteng, South Africa; UCB Clinical Trial Call Center
Randomized Evaluation of the 24-Hour Coverage: Efficacy of Rotigotine
Tygerberg, South Africa; UCB Clinical Trial Call Center
Randomized Evaluation of the 24-Hour Coverage: Efficacy of Rotigotine
Alicante, Spain; UCB Clinical Trial Call Center
Transdermal Rotigotine User Surveillance Study
Alzira, Spain; UCB Clinical Trial Call Center
Randomized Evaluation of the 24-Hour Coverage: Efficacy of Rotigotine
Barakaldo, Spain; UCB Clinical Trial Call Center
Randomized Evaluation of the 24-Hour Coverage: Efficacy of Rotigotine
Barcelona, Spain; UCB Clinical Trial Call Center
Transdermal Rotigotine User Surveillance Study
Barcelona, Spain; Hospital de la Santa Creu i de Sant Pau
A clinical study designed to help reduce uncontrolled movements and rigidity caused by levodopa in people with Parkinson’s disease.
Barcelona, Spain; UCB Clinical Trial Call Center
Randomized Evaluation of the 24-Hour Coverage: Efficacy of Rotigotine
Burgos, Spain; UCB Clinical Trial Call Center
Transdermal Rotigotine User Surveillance Study
Córdoba, Spain; UCB Clinical Trial Call Center
Transdermal Rotigotine User Surveillance Study
Ciudad Real, Spain; UCB Clinical Trial Call Center
Transdermal Rotigotine User Surveillance Study
Girona, Spain; UCB Clinical Trial Call Center
Transdermal Rotigotine User Surveillance Study
La Linea de la Concepcion, Spain; UCB Clinical Trial Call Center
Transdermal Rotigotine User Surveillance Study
Las Palmas de Gran Canaria, Spain; UCB Clinical Trial Call Center
Transdermal Rotigotine User Surveillance Study
Madrid, Spain; UCB Clinical Trial Call Center
Transdermal Rotigotine User Surveillance Study
Madrid, Spain; Hospital Gregorio Maranon
A clinical study designed to help reduce uncontrolled movements and rigidity caused by levodopa in people with Parkinson’s disease.
Madrid, Spain; UCB Clinical Trial Call Center
Randomized Evaluation of the 24-Hour Coverage: Efficacy of Rotigotine
Madrid, Spain; UCB Clinical Trial Call Center
Randomized Evaluation of the 24-Hour Coverage: Efficacy of Rotigotine
Madrid, Spain; UCB Clinical Trial Call Center
Randomized Evaluation of the 24-Hour Coverage: Efficacy of Rotigotine
Oviedo, Spain; UCB Clinical Trial Call Center
Transdermal Rotigotine User Surveillance Study
Palma de Mallorca, Spain; UCB Clinical Trial Call Center
Transdermal Rotigotine User Surveillance Study
Sant Cugat del Vallés, Spain; UCB Clinical Trial Call Center
Transdermal Rotigotine User Surveillance Study
Sevilla, Spain; UCB Clinical Trial Call Center
Transdermal Rotigotine User Surveillance Study
Valencia, Spain; UCB Clinical Trial Call Center
Transdermal Rotigotine User Surveillance Study
Bristol, United Kingdom; UCB Clinical Trial Call Center
Randomized Evaluation of the 24-Hour Coverage: Efficacy of Rotigotine
Lancashire, United Kingdom; UCB Clinical Trial Call Center
Randomized Evaluation of the 24-Hour Coverage: Efficacy of Rotigotine
Liverpool, United Kingdom; UCB Clinical Trial Call Center
Randomized Evaluation of the 24-Hour Coverage: Efficacy of Rotigotine
London, United Kingdom; UCB Clinical Trial Call Center
Randomized Evaluation of the 24-Hour Coverage: Efficacy of Rotigotine
North Shields, United Kingdom; UCB Clinical Trial Call Center
Randomized Evaluation of the 24-Hour Coverage: Efficacy of Rotigotine
